Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Goldberg

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|March 5, 2011
Phase I trial of metronomic oral vinorelbine in patients with advanced cancerLakshmi Rajdev, Abdissa Negassa, Qun Dai, et al.
American Journal of Physical Medicine & Rehabilitation|June 24, 2003
Physical medicine and rehabilitation consultation: relationships with acute functional outcome, length of stay, and discharge planning after traumatic brain injuryAmy K Wagner, Tony Fabio, Ross D Zafonte, et al.
Journal of Gynecologic Oncology|April 16, 2015
Physical activity for an ethnically diverse sample of endometrial cancer survivors: a needs assessment and pilot interventionAmerigo Rossi, Alyson Moadel-Robblee, Carol Ewing Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93Scott Wadler, Donna E Levy, Sarah T Lincoln, et al.
Journal of Neurotrauma|September 30, 2014
Structured interview for mild traumatic brain injury after military blast: inter-rater agreement and development of diagnostic algorithmWilliam C Walker, David X Cifu, Anne M Hudak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in patients with refractory solid tumorsSanjay Goel, Kavita Desai, Anca Bulgaru, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|February 25, 2015
Carbon footprint of robotically-assisted laparoscopy, laparoscopy and laparotomy: a comparisonDemetrius L Woods, Thomas McAndrew, Nicole Nevadunsky, et al.
Gynecologic Oncology|March 30, 2004
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group studyFarr Nezhat, Scott Wadler, Franco Muggia, et al.
Gynecologic Oncology|October 29, 2005
Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG studyHoward S Hochster, Elizabeth R Plimack, John Mandeli, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervixJonathan J Beitler, Patrick Anderson, Hilda Haynes, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|March 5, 2011
Phase I trial of metronomic oral vinorelbine in patients with advanced cancerLakshmi Rajdev, Abdissa Negassa, Qun Dai, et al.
American Journal of Physical Medicine & Rehabilitation|June 24, 2003
Physical medicine and rehabilitation consultation: relationships with acute functional outcome, length of stay, and discharge planning after traumatic brain injuryAmy K Wagner, Tony Fabio, Ross D Zafonte, et al.
Journal of Gynecologic Oncology|April 16, 2015
Physical activity for an ethnically diverse sample of endometrial cancer survivors: a needs assessment and pilot interventionAmerigo Rossi, Alyson Moadel-Robblee, Carol Ewing Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93Scott Wadler, Donna E Levy, Sarah T Lincoln, et al.
Journal of Neurotrauma|September 30, 2014
Structured interview for mild traumatic brain injury after military blast: inter-rater agreement and development of diagnostic algorithmWilliam C Walker, David X Cifu, Anne M Hudak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in patients with refractory solid tumorsSanjay Goel, Kavita Desai, Anca Bulgaru, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|February 25, 2015
Carbon footprint of robotically-assisted laparoscopy, laparoscopy and laparotomy: a comparisonDemetrius L Woods, Thomas McAndrew, Nicole Nevadunsky, et al.
Gynecologic Oncology|March 30, 2004
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group studyFarr Nezhat, Scott Wadler, Franco Muggia, et al.
Gynecologic Oncology|October 29, 2005
Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG studyHoward S Hochster, Elizabeth R Plimack, John Mandeli, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervixJonathan J Beitler, Patrick Anderson, Hilda Haynes, et al.
Pageof 4